nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketorolac—PTGS1—malignant glioma	0.54	0.636	CbGaD
Ketorolac—PTGS2—malignant glioma	0.309	0.364	CbGaD
Ketorolac—Infertility—Carmustine—malignant glioma	0.00411	0.0329	CcSEcCtD
Ketorolac—Infertility—Temozolomide—malignant glioma	0.00397	0.0318	CcSEcCtD
Ketorolac—Retinal haemorrhage—Carmustine—malignant glioma	0.00329	0.0263	CcSEcCtD
Ketorolac—Paranoid reaction—Carmustine—malignant glioma	0.00252	0.0202	CcSEcCtD
Ketorolac—Azotaemia—Carmustine—malignant glioma	0.00201	0.0161	CcSEcCtD
Ketorolac—Cerebration impaired—Temozolomide—malignant glioma	0.00176	0.0141	CcSEcCtD
Ketorolac—Paranoia—Carmustine—malignant glioma	0.00157	0.0126	CcSEcCtD
Ketorolac—Stupor—Carmustine—malignant glioma	0.00144	0.0115	CcSEcCtD
Ketorolac—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00138	0.011	CcSEcCtD
Ketorolac—Coagulopathy—Temozolomide—malignant glioma	0.00133	0.0107	CcSEcCtD
Ketorolac—Injection site pain—Carmustine—malignant glioma	0.00131	0.0105	CcSEcCtD
Ketorolac—Speech disorder—Carmustine—malignant glioma	0.00125	0.00998	CcSEcCtD
Ketorolac—Speech disorder—Temozolomide—malignant glioma	0.0012	0.00964	CcSEcCtD
Ketorolac—Disturbance in attention—Temozolomide—malignant glioma	0.0012	0.00957	CcSEcCtD
Ketorolac—Thinking abnormal—Carmustine—malignant glioma	0.00117	0.00937	CcSEcCtD
Ketorolac—Hepatic enzyme increased—Temozolomide—malignant glioma	0.0011	0.00877	CcSEcCtD
Ketorolac—Hearing impaired—Temozolomide—malignant glioma	0.00109	0.00871	CcSEcCtD
Ketorolac—Neck pain—Carmustine—malignant glioma	0.00108	0.00868	CcSEcCtD
Ketorolac—Pulmonary embolism—Carmustine—malignant glioma	0.00107	0.00858	CcSEcCtD
Ketorolac—Injection site reaction—Carmustine—malignant glioma	0.00107	0.00853	CcSEcCtD
Ketorolac—Tolmetin—CXCL8—malignant glioma	0.00106	0.14	CrCbGaD
Ketorolac—Vaginal inflammation—Temozolomide—malignant glioma	0.00104	0.00829	CcSEcCtD
Ketorolac—Pulmonary embolism—Temozolomide—malignant glioma	0.00104	0.00829	CcSEcCtD
Ketorolac—Depressed level of consciousness—Carmustine—malignant glioma	0.00104	0.00829	CcSEcCtD
Ketorolac—Depressed level of consciousness—Temozolomide—malignant glioma	0.001	0.00801	CcSEcCtD
Ketorolac—Coma—Carmustine—malignant glioma	0.000979	0.00784	CcSEcCtD
Ketorolac—Vaginal infection—Temozolomide—malignant glioma	0.000978	0.00783	CcSEcCtD
Ketorolac—Aplastic anaemia—Temozolomide—malignant glioma	0.000973	0.00779	CcSEcCtD
Ketorolac—Dry eye—Temozolomide—malignant glioma	0.000957	0.00766	CcSEcCtD
Ketorolac—Abnormal vision—Carmustine—malignant glioma	0.000935	0.00748	CcSEcCtD
Ketorolac—Sepsis—Carmustine—malignant glioma	0.00093	0.00745	CcSEcCtD
Ketorolac—Mental disability—Carmustine—malignant glioma	0.00093	0.00745	CcSEcCtD
Ketorolac—Abnormal vision—Temozolomide—malignant glioma	0.000903	0.00723	CcSEcCtD
Ketorolac—Mental disability—Temozolomide—malignant glioma	0.000899	0.0072	CcSEcCtD
Ketorolac—Swelling—Carmustine—malignant glioma	0.000882	0.00706	CcSEcCtD
Ketorolac—Ear pain—Temozolomide—malignant glioma	0.000881	0.00705	CcSEcCtD
Ketorolac—Eye pain—Carmustine—malignant glioma	0.000862	0.0069	CcSEcCtD
Ketorolac—Injury—Carmustine—malignant glioma	0.000847	0.00678	CcSEcCtD
Ketorolac—Vascular purpura—Temozolomide—malignant glioma	0.000841	0.00673	CcSEcCtD
Ketorolac—Deafness—Temozolomide—malignant glioma	0.000841	0.00673	CcSEcCtD
Ketorolac—Hepatic failure—Temozolomide—malignant glioma	0.000837	0.0067	CcSEcCtD
Ketorolac—Eye pain—Temozolomide—malignant glioma	0.000833	0.00667	CcSEcCtD
Ketorolac—Dermatitis exfoliative—Temozolomide—malignant glioma	0.000797	0.00638	CcSEcCtD
Ketorolac—Thirst—Temozolomide—malignant glioma	0.00079	0.00632	CcSEcCtD
Ketorolac—Hyponatraemia—Carmustine—malignant glioma	0.000781	0.00625	CcSEcCtD
Ketorolac—Purpura—Temozolomide—malignant glioma	0.00078	0.00624	CcSEcCtD
Ketorolac—Diplopia—Carmustine—malignant glioma	0.000778	0.00623	CcSEcCtD
Ketorolac—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000778	0.00623	CcSEcCtD
Ketorolac—Diplopia—Temozolomide—malignant glioma	0.000752	0.00602	CcSEcCtD
Ketorolac—Face oedema—Carmustine—malignant glioma	0.000751	0.00601	CcSEcCtD
Ketorolac—Face oedema—Temozolomide—malignant glioma	0.000726	0.00581	CcSEcCtD
Ketorolac—Liver function test abnormal—Carmustine—malignant glioma	0.000718	0.00575	CcSEcCtD
Ketorolac—Hypokalaemia—Carmustine—malignant glioma	0.000708	0.00567	CcSEcCtD
Ketorolac—PTGS2—S1P1 pathway—SPHK1—malignant glioma	0.000686	0.0375	CbGpPWpGaD
Ketorolac—Tiaprofenic acid—PTGS1—malignant glioma	0.000685	0.0902	CrCbGaD
Ketorolac—Hypokalaemia—Temozolomide—malignant glioma	0.000684	0.00548	CcSEcCtD
Ketorolac—Breast disorder—Temozolomide—malignant glioma	0.000679	0.00544	CcSEcCtD
Ketorolac—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000677	0.00542	CcSEcCtD
Ketorolac—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.000677	0.00542	CcSEcCtD
Ketorolac—Abdominal distension—Temozolomide—malignant glioma	0.000654	0.00524	CcSEcCtD
Ketorolac—Nepafenac—PTGS1—malignant glioma	0.000651	0.0858	CrCbGaD
Ketorolac—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS1—malignant glioma	0.00065	0.0355	CbGpPWpGaD
Ketorolac—Pancytopenia—Carmustine—malignant glioma	0.000639	0.00511	CcSEcCtD
Ketorolac—Sweating increased—Temozolomide—malignant glioma	0.000633	0.00507	CcSEcCtD
Ketorolac—Fenbufen—PTGS1—malignant glioma	0.000623	0.0821	CrCbGaD
Ketorolac—Pancytopenia—Temozolomide—malignant glioma	0.000617	0.00494	CcSEcCtD
Ketorolac—Dysuria—Temozolomide—malignant glioma	0.000608	0.00486	CcSEcCtD
Ketorolac—Hyperglycaemia—Carmustine—malignant glioma	0.000607	0.00486	CcSEcCtD
Ketorolac—Pneumonia—Carmustine—malignant glioma	0.000603	0.00483	CcSEcCtD
Ketorolac—Pollakiuria—Temozolomide—malignant glioma	0.0006	0.00481	CcSEcCtD
Ketorolac—Photosensitivity reaction—Temozolomide—malignant glioma	0.000593	0.00475	CcSEcCtD
Ketorolac—Weight increased—Temozolomide—malignant glioma	0.000591	0.00473	CcSEcCtD
Ketorolac—Renal failure—Carmustine—malignant glioma	0.000589	0.00472	CcSEcCtD
Ketorolac—Hyperglycaemia—Temozolomide—malignant glioma	0.000586	0.00469	CcSEcCtD
Ketorolac—Stomatitis—Carmustine—malignant glioma	0.000584	0.00468	CcSEcCtD
Ketorolac—Pneumonia—Temozolomide—malignant glioma	0.000583	0.00467	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—YEATS4—malignant glioma	0.000577	0.0315	CbGpPWpGaD
Ketorolac—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000574	0.0046	CcSEcCtD
Ketorolac—Stomatitis—Temozolomide—malignant glioma	0.000565	0.00452	CcSEcCtD
Ketorolac—Hepatobiliary disease—Temozolomide—malignant glioma	0.000548	0.00439	CcSEcCtD
Ketorolac—Tolmetin—PTGS1—malignant glioma	0.000541	0.0713	CrCbGaD
Ketorolac—Salsalate—PTGS1—malignant glioma	0.000541	0.0713	CrCbGaD
Ketorolac—Haemoglobin—Carmustine—malignant glioma	0.000541	0.00433	CcSEcCtD
Ketorolac—Haemorrhage—Carmustine—malignant glioma	0.000538	0.00431	CcSEcCtD
Ketorolac—Hallucination—Carmustine—malignant glioma	0.000536	0.00429	CcSEcCtD
Ketorolac—Connective tissue disorder—Carmustine—malignant glioma	0.000529	0.00423	CcSEcCtD
Ketorolac—Haemoglobin—Temozolomide—malignant glioma	0.000523	0.00419	CcSEcCtD
Ketorolac—Haemorrhage—Temozolomide—malignant glioma	0.00052	0.00416	CcSEcCtD
Ketorolac—Hepatitis—Temozolomide—malignant glioma	0.00052	0.00416	CcSEcCtD
Ketorolac—Suprofen—PTGS1—malignant glioma	0.000519	0.0684	CrCbGaD
Ketorolac—Visual impairment—Carmustine—malignant glioma	0.000519	0.00415	CcSEcCtD
Ketorolac—Hallucination—Temozolomide—malignant glioma	0.000518	0.00414	CcSEcCtD
Ketorolac—Ketoprofen—CXCL8—malignant glioma	0.000517	0.0682	CrCbGaD
Ketorolac—Urinary tract disorder—Temozolomide—malignant glioma	0.000514	0.00411	CcSEcCtD
Ketorolac—Connective tissue disorder—Temozolomide—malignant glioma	0.000511	0.00409	CcSEcCtD
Ketorolac—Urethral disorder—Temozolomide—malignant glioma	0.00051	0.00408	CcSEcCtD
Ketorolac—PTGS2—Overview of nanoparticle effects—PTGS1—malignant glioma	0.000509	0.0278	CbGpPWpGaD
Ketorolac—Eye disorder—Carmustine—malignant glioma	0.000503	0.00403	CcSEcCtD
Ketorolac—Visual impairment—Temozolomide—malignant glioma	0.000501	0.00401	CcSEcCtD
Ketorolac—Flushing—Carmustine—malignant glioma	0.0005	0.004	CcSEcCtD
Ketorolac—Erythema multiforme—Temozolomide—malignant glioma	0.000492	0.00394	CcSEcCtD
Ketorolac—Eye disorder—Temozolomide—malignant glioma	0.000486	0.00389	CcSEcCtD
Ketorolac—Tinnitus—Temozolomide—malignant glioma	0.000485	0.00388	CcSEcCtD
Ketorolac—Cardiac disorder—Temozolomide—malignant glioma	0.000483	0.00386	CcSEcCtD
Ketorolac—Flushing—Temozolomide—malignant glioma	0.000483	0.00386	CcSEcCtD
Ketorolac—Arrhythmia—Carmustine—malignant glioma	0.000481	0.00385	CcSEcCtD
Ketorolac—Alopecia—Carmustine—malignant glioma	0.000476	0.00381	CcSEcCtD
Ketorolac—Angiopathy—Temozolomide—malignant glioma	0.000472	0.00378	CcSEcCtD
Ketorolac—Mental disorder—Carmustine—malignant glioma	0.000472	0.00377	CcSEcCtD
Ketorolac—Immune system disorder—Temozolomide—malignant glioma	0.00047	0.00376	CcSEcCtD
Ketorolac—Mediastinal disorder—Temozolomide—malignant glioma	0.000469	0.00375	CcSEcCtD
Ketorolac—Erythema—Carmustine—malignant glioma	0.000469	0.00375	CcSEcCtD
Ketorolac—Malnutrition—Carmustine—malignant glioma	0.000469	0.00375	CcSEcCtD
Ketorolac—Chills—Temozolomide—malignant glioma	0.000467	0.00374	CcSEcCtD
Ketorolac—Alopecia—Temozolomide—malignant glioma	0.00046	0.00368	CcSEcCtD
Ketorolac—Mental disorder—Temozolomide—malignant glioma	0.000456	0.00365	CcSEcCtD
Ketorolac—Back pain—Carmustine—malignant glioma	0.000453	0.00363	CcSEcCtD
Ketorolac—Malnutrition—Temozolomide—malignant glioma	0.000453	0.00362	CcSEcCtD
Ketorolac—Erythema—Temozolomide—malignant glioma	0.000453	0.00362	CcSEcCtD
Ketorolac—PTGS1—Overview of nanoparticle effects—PTK2—malignant glioma	0.000447	0.0244	CbGpPWpGaD
Ketorolac—Dysgeusia—Temozolomide—malignant glioma	0.000443	0.00355	CcSEcCtD
Ketorolac—Vision blurred—Carmustine—malignant glioma	0.000442	0.00354	CcSEcCtD
Ketorolac—Tremor—Carmustine—malignant glioma	0.000439	0.00351	CcSEcCtD
Ketorolac—Back pain—Temozolomide—malignant glioma	0.000438	0.00351	CcSEcCtD
Ketorolac—Anaemia—Carmustine—malignant glioma	0.000433	0.00347	CcSEcCtD
Ketorolac—Agitation—Carmustine—malignant glioma	0.000431	0.00345	CcSEcCtD
Ketorolac—Vision blurred—Temozolomide—malignant glioma	0.000427	0.00342	CcSEcCtD
Ketorolac—Tremor—Temozolomide—malignant glioma	0.000424	0.0034	CcSEcCtD
Ketorolac—PTGS2—Eicosanoid Synthesis—PTGS1—malignant glioma	0.000423	0.0231	CbGpPWpGaD
Ketorolac—Ill-defined disorder—Temozolomide—malignant glioma	0.00042	0.00336	CcSEcCtD
Ketorolac—Leukopenia—Carmustine—malignant glioma	0.000419	0.00336	CcSEcCtD
Ketorolac—Anaemia—Temozolomide—malignant glioma	0.000419	0.00335	CcSEcCtD
Ketorolac—Agitation—Temozolomide—malignant glioma	0.000416	0.00333	CcSEcCtD
Ketorolac—Angioedema—Temozolomide—malignant glioma	0.000414	0.00331	CcSEcCtD
Ketorolac—Malaise—Temozolomide—malignant glioma	0.000408	0.00327	CcSEcCtD
Ketorolac—Vertigo—Temozolomide—malignant glioma	0.000407	0.00326	CcSEcCtD
Ketorolac—Convulsion—Carmustine—malignant glioma	0.000406	0.00325	CcSEcCtD
Ketorolac—Leukopenia—Temozolomide—malignant glioma	0.000405	0.00324	CcSEcCtD
Ketorolac—Hypertension—Carmustine—malignant glioma	0.000405	0.00324	CcSEcCtD
Ketorolac—Palpitations—Temozolomide—malignant glioma	0.0004	0.0032	CcSEcCtD
Ketorolac—Chest pain—Carmustine—malignant glioma	0.000399	0.00319	CcSEcCtD
Ketorolac—Myalgia—Carmustine—malignant glioma	0.000399	0.00319	CcSEcCtD
Ketorolac—Anxiety—Carmustine—malignant glioma	0.000398	0.00318	CcSEcCtD
Ketorolac—Cough—Temozolomide—malignant glioma	0.000395	0.00316	CcSEcCtD
Ketorolac—Convulsion—Temozolomide—malignant glioma	0.000392	0.00314	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—ROS1—malignant glioma	0.000392	0.0214	CbGpPWpGaD
Ketorolac—Tiaprofenic acid—PTGS2—malignant glioma	0.000391	0.0516	CrCbGaD
Ketorolac—Hypertension—Temozolomide—malignant glioma	0.000391	0.00313	CcSEcCtD
Ketorolac—Confusional state—Carmustine—malignant glioma	0.000386	0.00309	CcSEcCtD
Ketorolac—Arthralgia—Temozolomide—malignant glioma	0.000386	0.00309	CcSEcCtD
Ketorolac—Myalgia—Temozolomide—malignant glioma	0.000386	0.00309	CcSEcCtD
Ketorolac—Anxiety—Temozolomide—malignant glioma	0.000384	0.00308	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000383	0.00306	CcSEcCtD
Ketorolac—Oedema—Carmustine—malignant glioma	0.000382	0.00306	CcSEcCtD
Ketorolac—Discomfort—Temozolomide—malignant glioma	0.000381	0.00305	CcSEcCtD
Ketorolac—Infection—Carmustine—malignant glioma	0.00038	0.00304	CcSEcCtD
Ketorolac—Dry mouth—Temozolomide—malignant glioma	0.000377	0.00302	CcSEcCtD
Ketorolac—Thrombocytopenia—Carmustine—malignant glioma	0.000374	0.003	CcSEcCtD
Ketorolac—Tachycardia—Carmustine—malignant glioma	0.000373	0.00299	CcSEcCtD
Ketorolac—Confusional state—Temozolomide—malignant glioma	0.000373	0.00298	CcSEcCtD
Ketorolac—Nepafenac—PTGS2—malignant glioma	0.000372	0.049	CrCbGaD
Ketorolac—Anaphylactic shock—Temozolomide—malignant glioma	0.00037	0.00296	CcSEcCtD
Ketorolac—Oedema—Temozolomide—malignant glioma	0.00037	0.00296	CcSEcCtD
Ketorolac—Infection—Temozolomide—malignant glioma	0.000367	0.00294	CcSEcCtD
Ketorolac—Anorexia—Carmustine—malignant glioma	0.000365	0.00292	CcSEcCtD
Ketorolac—Nervous system disorder—Temozolomide—malignant glioma	0.000362	0.0029	CcSEcCtD
Ketorolac—Thrombocytopenia—Temozolomide—malignant glioma	0.000362	0.0029	CcSEcCtD
Ketorolac—Skin disorder—Temozolomide—malignant glioma	0.000359	0.00287	CcSEcCtD
Ketorolac—Hypotension—Carmustine—malignant glioma	0.000357	0.00286	CcSEcCtD
Ketorolac—Hyperhidrosis—Temozolomide—malignant glioma	0.000357	0.00286	CcSEcCtD
Ketorolac—Fenbufen—PTGS2—malignant glioma	0.000356	0.0469	CrCbGaD
Ketorolac—PTGS2—Overview of nanoparticle effects—PTK2—malignant glioma	0.000355	0.0194	CbGpPWpGaD
Ketorolac—PTGS2—Prostaglandin Synthesis and Regulation—PTGS1—malignant glioma	0.000353	0.0193	CbGpPWpGaD
Ketorolac—Anorexia—Temozolomide—malignant glioma	0.000352	0.00282	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000348	0.00279	CcSEcCtD
Ketorolac—Insomnia—Carmustine—malignant glioma	0.000346	0.00277	CcSEcCtD
Ketorolac—Paraesthesia—Carmustine—malignant glioma	0.000343	0.00275	CcSEcCtD
Ketorolac—Dyspnoea—Carmustine—malignant glioma	0.000341	0.00273	CcSEcCtD
Ketorolac—Somnolence—Carmustine—malignant glioma	0.00034	0.00272	CcSEcCtD
Ketorolac—PTGS1—Overview of nanoparticle effects—FN1—malignant glioma	0.000338	0.0185	CbGpPWpGaD
Ketorolac—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000337	0.0027	CcSEcCtD
Ketorolac—Insomnia—Temozolomide—malignant glioma	0.000334	0.00268	CcSEcCtD
Ketorolac—Decreased appetite—Carmustine—malignant glioma	0.000332	0.00266	CcSEcCtD
Ketorolac—Paraesthesia—Temozolomide—malignant glioma	0.000332	0.00266	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—NF1—malignant glioma	0.000331	0.0181	CbGpPWpGaD
Ketorolac—Gastrointestinal disorder—Carmustine—malignant glioma	0.00033	0.00264	CcSEcCtD
Ketorolac—Dyspnoea—Temozolomide—malignant glioma	0.000329	0.00264	CcSEcCtD
Ketorolac—Somnolence—Temozolomide—malignant glioma	0.000329	0.00263	CcSEcCtD
Ketorolac—Constipation—Carmustine—malignant glioma	0.000327	0.00262	CcSEcCtD
Ketorolac—Pain—Carmustine—malignant glioma	0.000327	0.00262	CcSEcCtD
Ketorolac—Dyspepsia—Temozolomide—malignant glioma	0.000325	0.0026	CcSEcCtD
Ketorolac—Decreased appetite—Temozolomide—malignant glioma	0.000321	0.00257	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000319	0.00255	CcSEcCtD
Ketorolac—Fatigue—Temozolomide—malignant glioma	0.000319	0.00255	CcSEcCtD
Ketorolac—Constipation—Temozolomide—malignant glioma	0.000316	0.00253	CcSEcCtD
Ketorolac—Pain—Temozolomide—malignant glioma	0.000316	0.00253	CcSEcCtD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000316	0.0172	CbGpPWpGaD
Ketorolac—Feeling abnormal—Carmustine—malignant glioma	0.000315	0.00252	CcSEcCtD
Ketorolac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—malignant glioma	0.000314	0.0172	CbGpPWpGaD
Ketorolac—Gastrointestinal pain—Carmustine—malignant glioma	0.000313	0.0025	CcSEcCtD
Ketorolac—Tolmetin—PTGS2—malignant glioma	0.000309	0.0408	CrCbGaD
Ketorolac—Salsalate—PTGS2—malignant glioma	0.000309	0.0408	CrCbGaD
Ketorolac—Feeling abnormal—Temozolomide—malignant glioma	0.000305	0.00244	CcSEcCtD
Ketorolac—Body temperature increased—Carmustine—malignant glioma	0.000302	0.00242	CcSEcCtD
Ketorolac—Abdominal pain—Carmustine—malignant glioma	0.000302	0.00242	CcSEcCtD
Ketorolac—Gastrointestinal pain—Temozolomide—malignant glioma	0.000302	0.00242	CcSEcCtD
Ketorolac—PTGS2—S1P1 pathway—PDGFB—malignant glioma	0.000298	0.0163	CbGpPWpGaD
Ketorolac—Suprofen—PTGS2—malignant glioma	0.000297	0.0391	CrCbGaD
Ketorolac—PTGS2—C-MYB transcription factor network—PIM1—malignant glioma	0.000295	0.0161	CbGpPWpGaD
Ketorolac—Urticaria—Temozolomide—malignant glioma	0.000294	0.00235	CcSEcCtD
Ketorolac—Body temperature increased—Temozolomide—malignant glioma	0.000292	0.00234	CcSEcCtD
Ketorolac—Abdominal pain—Temozolomide—malignant glioma	0.000292	0.00234	CcSEcCtD
Ketorolac—PTGS1—Overview of nanoparticle effects—PIK3CD—malignant glioma	0.000285	0.0156	CbGpPWpGaD
Ketorolac—Hypersensitivity—Carmustine—malignant glioma	0.000282	0.00226	CcSEcCtD
Ketorolac—PTGS2—S1P1 pathway—KDR—malignant glioma	0.000279	0.0153	CbGpPWpGaD
Ketorolac—Asthenia—Carmustine—malignant glioma	0.000274	0.0022	CcSEcCtD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000274	0.0149	CbGpPWpGaD
Ketorolac—Hypersensitivity—Temozolomide—malignant glioma	0.000272	0.00218	CcSEcCtD
Ketorolac—PTGS2—Overview of nanoparticle effects—FN1—malignant glioma	0.000269	0.0147	CbGpPWpGaD
Ketorolac—Asthenia—Temozolomide—malignant glioma	0.000265	0.00212	CcSEcCtD
Ketorolac—Ketoprofen—PTGS1—malignant glioma	0.000264	0.0348	CrCbGaD
Ketorolac—Diarrhoea—Carmustine—malignant glioma	0.000262	0.00209	CcSEcCtD
Ketorolac—Pruritus—Temozolomide—malignant glioma	0.000261	0.00209	CcSEcCtD
Ketorolac—PTGS1—Overview of nanoparticle effects—BCL2—malignant glioma	0.000259	0.0141	CbGpPWpGaD
Ketorolac—Dizziness—Carmustine—malignant glioma	0.000253	0.00202	CcSEcCtD
Ketorolac—Diarrhoea—Temozolomide—malignant glioma	0.000253	0.00202	CcSEcCtD
Ketorolac—PTGS1—Overview of nanoparticle effects—PTGS2—malignant glioma	0.000246	0.0134	CbGpPWpGaD
Ketorolac—Dizziness—Temozolomide—malignant glioma	0.000244	0.00196	CcSEcCtD
Ketorolac—Vomiting—Carmustine—malignant glioma	0.000243	0.00195	CcSEcCtD
Ketorolac—Rash—Carmustine—malignant glioma	0.000241	0.00193	CcSEcCtD
Ketorolac—Dermatitis—Carmustine—malignant glioma	0.000241	0.00193	CcSEcCtD
Ketorolac—Headache—Carmustine—malignant glioma	0.00024	0.00192	CcSEcCtD
Ketorolac—PTGS1—Overview of nanoparticle effects—CXCL8—malignant glioma	0.000238	0.013	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—BCAN—malignant glioma	0.000237	0.013	CbGpPWpGaD
Ketorolac—Vomiting—Temozolomide—malignant glioma	0.000235	0.00188	CcSEcCtD
Ketorolac—PTGS2—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000235	0.0128	CbGpPWpGaD
Ketorolac—Rash—Temozolomide—malignant glioma	0.000233	0.00187	CcSEcCtD
Ketorolac—Dermatitis—Temozolomide—malignant glioma	0.000233	0.00186	CcSEcCtD
Ketorolac—Headache—Temozolomide—malignant glioma	0.000232	0.00185	CcSEcCtD
Ketorolac—Nausea—Carmustine—malignant glioma	0.000227	0.00182	CcSEcCtD
Ketorolac—PTGS2—Overview of nanoparticle effects—PIK3CD—malignant glioma	0.000226	0.0124	CbGpPWpGaD
Ketorolac—Nausea—Temozolomide—malignant glioma	0.00022	0.00176	CcSEcCtD
Ketorolac—PTGS2—Overview of nanoparticle effects—BCL2—malignant glioma	0.000205	0.0112	CbGpPWpGaD
Ketorolac—PTGS1—Eicosanoid Synthesis—PTGS2—malignant glioma	0.000204	0.0111	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—MYB—malignant glioma	0.000197	0.0108	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—GDNF—malignant glioma	0.000191	0.0105	CbGpPWpGaD
Ketorolac—PTGS2—Overview of nanoparticle effects—CXCL8—malignant glioma	0.000189	0.0103	CbGpPWpGaD
Ketorolac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—malignant glioma	0.000176	0.00964	CbGpPWpGaD
Ketorolac—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—malignant glioma	0.000171	0.00932	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—CYP2B6—malignant glioma	0.000168	0.00916	CbGpPWpGaD
Ketorolac—PTGS1—Overview of nanoparticle effects—TNF—malignant glioma	0.000166	0.00907	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—GFAP—malignant glioma	0.000164	0.00899	CbGpPWpGaD
Ketorolac—PTGS2—S1P1 pathway—VEGFA—malignant glioma	0.000154	0.0084	CbGpPWpGaD
Ketorolac—Ketoprofen—PTGS2—malignant glioma	0.000151	0.0199	CrCbGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—PTGS1—malignant glioma	0.000149	0.00817	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—CYP2C18—malignant glioma	0.000145	0.00794	CbGpPWpGaD
Ketorolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—malignant glioma	0.000145	0.00793	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—LGALS3—malignant glioma	0.000144	0.00786	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—SOD1—malignant glioma	0.000143	0.0078	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.000137	0.0075	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—CAT—malignant glioma	0.000136	0.0074	CbGpPWpGaD
Ketorolac—PTGS2—Overview of nanoparticle effects—TNF—malignant glioma	0.000132	0.0072	CbGpPWpGaD
Ketorolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—malignant glioma	0.000129	0.00705	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—GSTT1—malignant glioma	0.000118	0.00642	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—malignant glioma	0.000114	0.00625	CbGpPWpGaD
Ketorolac—PTGS1—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000113	0.0062	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—SOD1—malignant glioma	0.000113	0.00619	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—CAT—malignant glioma	0.000108	0.00588	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—HES1—malignant glioma	0.000106	0.00579	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—NCOR1—malignant glioma	0.000105	0.00576	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.000104	0.00568	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	9.95e-05	0.00544	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—F2—malignant glioma	9.93e-05	0.00543	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	9.86e-05	0.00539	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—malignant glioma	9.39e-05	0.00513	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—GJA1—malignant glioma	9.27e-05	0.00506	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	8.79e-05	0.0048	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—malignant glioma	8.73e-05	0.00477	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—malignant glioma	8.36e-05	0.00457	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—malignant glioma	8.34e-05	0.00456	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—RTEL1—malignant glioma	8.24e-05	0.0045	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—GSTP1—malignant glioma	8.15e-05	0.00445	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	8.04e-05	0.00439	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—F2—malignant glioma	7.88e-05	0.00431	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	7.58e-05	0.00414	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—IFNG—malignant glioma	7.52e-05	0.00411	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—PTGS2—malignant glioma	7.21e-05	0.00394	CbGpPWpGaD
Ketorolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—malignant glioma	7.13e-05	0.00389	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	6.97e-05	0.00381	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	6.82e-05	0.00373	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—IL1B—malignant glioma	6.71e-05	0.00367	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—RTEL1—malignant glioma	6.54e-05	0.00357	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	6.5e-05	0.00355	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	6.44e-05	0.00352	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—CDKN2A—malignant glioma	6.36e-05	0.00347	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—BCL2—malignant glioma	6.26e-05	0.00342	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	6.25e-05	0.00342	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malignant glioma	6.08e-05	0.00332	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—IFNG—malignant glioma	5.97e-05	0.00326	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	5.89e-05	0.00322	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	5.81e-05	0.00318	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	5.76e-05	0.00315	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	5.7e-05	0.00311	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—IL1B—malignant glioma	5.33e-05	0.00291	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	5.23e-05	0.00286	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—TNF—malignant glioma	4.87e-05	0.00266	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—COX8A—malignant glioma	4.73e-05	0.00259	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—IFNG—malignant glioma	4.72e-05	0.00258	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	4.68e-05	0.00256	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	4.67e-05	0.00255	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	4.52e-05	0.00247	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—CXCL8—malignant glioma	4.39e-05	0.0024	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—MYC—malignant glioma	4.31e-05	0.00235	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—IL1B—malignant glioma	4.21e-05	0.0023	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—CASP3—malignant glioma	4.2e-05	0.0023	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—IL2—malignant glioma	4.2e-05	0.00229	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	4.19e-05	0.00229	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	4.06e-05	0.00222	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ASMT—malignant glioma	4.02e-05	0.0022	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	4.01e-05	0.00219	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—KRAS—malignant glioma	3.98e-05	0.00218	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—MMP9—malignant glioma	3.97e-05	0.00217	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.93e-05	0.00215	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—TNF—malignant glioma	3.87e-05	0.00211	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—BCAN—malignant glioma	3.78e-05	0.00207	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—COX8A—malignant glioma	3.76e-05	0.00205	CbGpPWpGaD
Ketorolac—PTGS2—Disease—BCAN—malignant glioma	3.58e-05	0.00196	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	3.42e-05	0.00187	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.36e-05	0.00183	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—MYC—malignant glioma	3.28e-05	0.00179	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	3.24e-05	0.00177	CbGpPWpGaD
Ketorolac—PTGS2—Disease—DTX1—malignant glioma	3.24e-05	0.00177	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—EGFR—malignant glioma	3.21e-05	0.00175	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	3.2e-05	0.00175	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ASMT—malignant glioma	3.19e-05	0.00174	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	3.18e-05	0.00174	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	3.15e-05	0.00172	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.12e-05	0.00171	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—TNF—malignant glioma	3.06e-05	0.00167	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—IDH2—malignant glioma	3.05e-05	0.00167	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—BCAN—malignant glioma	3e-05	0.00164	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.87e-05	0.00157	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP2B6—malignant glioma	2.87e-05	0.00157	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	2.86e-05	0.00156	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—TP53—malignant glioma	2.7e-05	0.00147	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	2.69e-05	0.00147	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—IDH1—malignant glioma	2.62e-05	0.00143	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HEY2—malignant glioma	2.54e-05	0.00139	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—SPHK1—malignant glioma	2.54e-05	0.00139	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP2C18—malignant glioma	2.49e-05	0.00136	CbGpPWpGaD
Ketorolac—PTGS2—Disease—IDH1—malignant glioma	2.48e-05	0.00136	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	2.43e-05	0.00133	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—IDH2—malignant glioma	2.42e-05	0.00132	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HEY1—malignant glioma	2.36e-05	0.00129	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.34e-05	0.00128	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HIST1H3B—malignant glioma	2.29e-05	0.00125	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.28e-05	0.00125	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP2B6—malignant glioma	2.28e-05	0.00124	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	2.23e-05	0.00122	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	2.18e-05	0.00119	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.13e-05	0.00117	CbGpPWpGaD
Ketorolac—PTGS2—Disease—JAG2—malignant glioma	2.09e-05	0.00114	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—IDH1—malignant glioma	2.08e-05	0.00114	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	2.08e-05	0.00114	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	2.06e-05	0.00113	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.06e-05	0.00113	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SPHK1—malignant glioma	2.01e-05	0.0011	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTT1—malignant glioma	2.01e-05	0.0011	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP2C18—malignant glioma	1.97e-05	0.00108	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	1.9e-05	0.00104	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.88e-05	0.00103	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.86e-05	0.00102	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	1.83e-05	0.001	CbGpPWpGaD
Ketorolac—PTGS2—Disease—H3F3A—malignant glioma	1.77e-05	0.000966	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—BCHE—malignant glioma	1.75e-05	0.000957	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—SLC5A5—malignant glioma	1.73e-05	0.000945	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.69e-05	0.000926	CbGpPWpGaD
Ketorolac—PTGS2—Disease—JAG1—malignant glioma	1.67e-05	0.000911	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.64e-05	0.000894	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.64e-05	0.000894	CbGpPWpGaD
Ketorolac—PTGS2—Disease—FBXW7—malignant glioma	1.63e-05	0.000892	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.62e-05	0.000886	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTT1—malignant glioma	1.6e-05	0.000872	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.55e-05	0.000846	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PTGS1—malignant glioma	1.5e-05	0.000817	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.49e-05	0.000814	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.41e-05	0.000772	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTP1—malignant glioma	1.39e-05	0.000761	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—BCHE—malignant glioma	1.39e-05	0.00076	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SLC5A5—malignant glioma	1.37e-05	0.00075	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CAT—malignant glioma	1.36e-05	0.000741	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.3e-05	0.00071	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NCOR1—malignant glioma	1.28e-05	0.0007	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CDKN2B—malignant glioma	1.28e-05	0.000699	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HES1—malignant glioma	1.22e-05	0.000667	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NCOR1—malignant glioma	1.21e-05	0.000663	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PDGFRA—malignant glioma	1.16e-05	0.000635	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.12e-05	0.000613	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTP1—malignant glioma	1.11e-05	0.000604	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CAT—malignant glioma	1.08e-05	0.000588	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TERT—malignant glioma	1.07e-05	0.000584	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HLA-A—malignant glioma	1.07e-05	0.000584	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PDGFB—malignant glioma	1.04e-05	0.00057	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CAV1—malignant glioma	1.04e-05	0.00057	CbGpPWpGaD
Ketorolac—PTGS2—Disease—FGFR1—malignant glioma	1.04e-05	0.000567	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HIF1A—malignant glioma	1.02e-05	0.000559	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NCOR1—malignant glioma	1.02e-05	0.000555	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	9.97e-06	0.000545	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CAV1—malignant glioma	9.89e-06	0.000541	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PIK3CG—malignant glioma	9.51e-06	0.000519	CbGpPWpGaD
Ketorolac—PTGS2—Disease—BAD—malignant glioma	9.3e-06	0.000508	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NOTCH1—malignant glioma	9.21e-06	0.000504	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PPARG—malignant glioma	9.17e-06	0.000501	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CD80—malignant glioma	9.03e-06	0.000493	CbGpPWpGaD
Ketorolac—PTGS2—Disease—APC—malignant glioma	9.01e-06	0.000492	CbGpPWpGaD
Ketorolac—PTGS2—Disease—EGF—malignant glioma	8.91e-06	0.000487	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PTPN11—malignant glioma	8.85e-06	0.000484	CbGpPWpGaD
Ketorolac—PTGS2—Disease—BRAF—malignant glioma	8.47e-06	0.000463	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PIK3CD—malignant glioma	8.36e-06	0.000457	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CAV1—malignant glioma	8.28e-06	0.000453	CbGpPWpGaD
Ketorolac—PTGS2—Disease—AKT2—malignant glioma	8.24e-06	0.000451	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PIK3CD—malignant glioma	7.92e-06	0.000433	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.92e-06	0.000433	CbGpPWpGaD
Ketorolac—PTGS2—Disease—FGF2—malignant glioma	7.58e-06	0.000414	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CG—malignant glioma	7.55e-06	0.000412	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PIK3CB—malignant glioma	7.28e-06	0.000398	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PPARG—malignant glioma	7.28e-06	0.000398	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PTGS2—malignant glioma	7.22e-06	0.000394	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MDM2—malignant glioma	7.1e-06	0.000388	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RAF1—malignant glioma	7.07e-06	0.000386	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ERBB2—malignant glioma	7e-06	0.000382	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PIK3CB—malignant glioma	6.9e-06	0.000377	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CD—malignant glioma	6.63e-06	0.000363	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PTEN—malignant glioma	6.29e-06	0.000344	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PTEN—malignant glioma	5.97e-06	0.000326	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CB—malignant glioma	5.78e-06	0.000316	CbGpPWpGaD
Ketorolac—PTGS2—Disease—STAT3—malignant glioma	5.34e-06	0.000292	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PTEN—malignant glioma	5e-06	0.000273	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MYC—malignant glioma	4.96e-06	0.000271	CbGpPWpGaD
Ketorolac—PTGS2—Disease—EGFR—malignant glioma	4.85e-06	0.000265	CbGpPWpGaD
Ketorolac—PTGS2—Disease—KRAS—malignant glioma	4.58e-06	0.00025	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PIK3CA—malignant glioma	4.44e-06	0.000243	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PIK3CA—malignant glioma	4.21e-06	0.00023	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—AKT1—malignant glioma	3.63e-06	0.000198	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CA—malignant glioma	3.52e-06	0.000193	CbGpPWpGaD
Ketorolac—PTGS2—Disease—AKT1—malignant glioma	3.44e-06	0.000188	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—AKT1—malignant glioma	2.88e-06	0.000157	CbGpPWpGaD
